Intracellular Processing of Pseudorabies Virus Glycoprotein M (gM): gM of Strain Bartha Lacks N-Glycosylation  by Dijkstra, Johannes M. et al.
VIROLOGY 237, 113–122 (1997)
ARTICLE NO. VY978766
Intracellular Processing of Pseudorabies Virus Glycoprotein M (gM):
gM of Strain Bartha Lacks N-Glycosylation
Johannes M. Dijkstra, Thomas C. Mettenleiter, and Barbara G. Klupp1
Institute of Molecular and Cellular Virology, Friedrich-Loeffler Institutes, Federal Research Centre
for Virus Diseases of Animals, D-17498 Insel Riems, Germany
Received May 8, 1997; returned to author for revisions July 8, 1997; accepted August 4, 1997
Genes encoding homologs of the herpes simplex virus type 1 UL10 product, glycoprotein M, are conserved in all
herpesviruses investigated so far. Recently, we identified pseudorabies virus (PrV) gM as a 45-kDa structural component
of purified virions. A gM0PrV mutant could be propagated in cell culture, albeit at lower titers and with delayed
penetration kinetics. Thus, gM has a nonessential but modulatory function in PrV infection. PrV gM is modified by
addition of an N-linked glycan at a consensus sequence located between the predicted first and second hydrophobic
region of the protein. This N-glycosylation site is conserved in all gM homologs sequenced so far, indicating an important
functional role. To analyze intracellular processing of PrV gM, Western blot analyses were performed. In PrV-infected
cells, mature 45-kDa gM as well as 33- and 35-kDa precursor forms were detectable. Presumably dimeric 90- and 70-
kDa proteins were also observed. The 33- and 35-kDa proteins represent nonglycosylated and glycosylated precursors
as shown by endoglycosidase digestions. Investigation of several PrV strains revealed that the UL10 product of PrV
strain Bartha, an attenuated virus used as vaccine, was not modified by N-glycosylation. Sequence analysis showed
that the N-glycosylation consensus sequence was altered from NDT to NDA, which resulted in loss of the N-glycosylation
signal. To our knowledge, this is the only gM homolog identified so far which is not N-glycosylated. To investigate
whether this form of the protein is functionally competent, the UL10 gene of strain Bartha was inserted into PrV strain
Kaplan by substitution of the wild-type UL10 gene. The resulting recombinant expressed a UL10 protein lacking N-
glycans. In vitro replication analyses did not reveal any difference in virus production, but plaque size and penetration
kinetics were slightly reduced. In summary, we show that wild-type gM is modified by N-glycosylation at one conserved
site. However, although this site is highly conserved throughout the herpesviruses, loss of N-glycans due to mutation
of the consensus sequence had only a minor effect on propagation of PrV in cell culture. q 1997 Academic Press
INTRODUCTION al., 1996; Osterrieder et al., 1996). Although amino acid
sequence of the gM proteins is only moderately homolo-
Herpesviruses encode a large number of glycopro-
gous, several features are present in all deduced pro-
teins, which are involved in various steps of the viral
teins. These are (i) a short hydrophilic stretch at the
replicative cycle and also constitute major targets for the amino terminus; (ii) eight hydrophobic regions of suffi-
immune response of the host. In PrV, a member of the cient length and hydrophobicity to span the lipid bilayer;
Alphaherpesvirinae, 11 glycoproteins have been identi- (iii) a highly charged carboxyterminus; (iv) a consensus
fied so far, which were designated on the basis of their sequence for addition of N-linked glycans present be-
homology to herpes simplex virus type 1 (HSV-1) proteins tween the first and second hydrophobic region. For PrV
as gB, gC, gD, gE, gG, gH, gI, gK, gL, and gM (reviewed gM this is the only N-glycan addition signal present (Dijk-
in Spear, 1993; Mettenleiter, 1994). The HSV-1 homolog stra et al., 1996).
of the last described PrV glycoprotein, gN (Jo¨ns et al., Although much is known about structure and biosyn-
1996), appears not to be glycosylated (Barnett et al., 1992, thesis of oligosaccharides in glycoproteins, the central
Adams et al., 1996). question of how glycosylation contributes to glycoprotein
Of these glycoproteins only gB, gH, gL, and gM seem structure and function is still a matter of debate. Effects
to be conserved throughout the herpesvirus family such as regulation of intracellular traffic and localization
(Spear, 1993). While gB, gH, and gL are essential for virus of glycoproteins, modification of immunological proper-
replication in cell culture in all herpesviruses studied so ties, or participation in cell–cell interactions have been
far (reviewed in Spear, 1993; Mettenleiter, 1994), gM is ascribed to particular structural properties of the carbo-
the only conserved nonessential glycoprotein (Baines hydrate moieties (West, 1986; Paulson, 1989). The overall
and Roizman, 1993; MacLean et al., 1993; Dijkstra et high similarity in composition and peripheral sequence of
carbohydrates may suggest general nonspecific effects
such as stabilization of the protein, protection from prote-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 49-38351-7151. olysis, or influence on nascent polypeptide chain folding
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(Olden et al., 1985; Wang et al., 1996; Wyss and Wagner, Plasmids and sequence determination
1996).
Cloned BamHI fragment 3 of PrV-Ka (kindly providedEffects of protein glycosylation on herpesvirus infectiv-
by T. Ben-Porat, Nashville, TN) was cleaved with SphIity has been investigated by the use of glycosylation
and BstEII, and a 4.7-kb subfragment containing the UL10inhibitors and by analysis of virions grown in cell lines
gene was cloned into vector TN47 (Mettenleiter, unpub-defective in the processing of oligosaccharide chains
lished). A 435-bp SalI fragment was removed after incom-(Johnson and Spear, 1982; summarized in Spear, 1993)
plete SalI digestion (see Fig. 1), and the SalI site wasas well as by endoglycosidase digestion (Ku¨hn et al.,
destroyed by Klenow fill-in and religation, which resulted1988). Use of glycosylation inhibitors inherently bears the
in plasmid TN47-913DSal. Cloned BamHI fragment 3 ofrisk of disturbance of normal cell function. Thus, their
PrV-Ba was cleaved with SphI, and the 9.8-kb SphI frag-specific effect on viral infectivity is difficult to assess.
ment comprising genes UL6 to UL13 (Dijkstra et al., 1997)Deglycosylation of glycoproteins on purified virions by
was cloned into pUC20 (Boehringer, Mannheim, Ger-endoglycosidase F reduced infectivity of HSV-1 ca. 10-
many). Incomplete SalI digestion and religation resultedfold (Ku¨hn et al., 1988).
in plasmid pUCBarthaSphIDSal.Studies with mutant proteins have shown that in the
For sequence determination of the strain Bartha UL10
absence of N-glycosylation some proteins fail to reach
gene a nested set of subclones (Henikoff, 1993) was
their correct cellular destination or are degraded (Ma-
prepared from plasmid pUCBarthaSphIDSal using a
chamer et al., 1985; Olden et al., 1985; Gallagher et al.,
commercially available kit (Nested Deletion kit, Phar-
1992; Qui et al., 1992a, 1992b; Li et al., 1993). In human
macia, Freiburg, Germany). Sequence was determined
immunodeficiency virus deletion of a single N-linked gly-
by the method of Sanger (Sanger et al., 1977) on double-
cosylation site from the transmembrane envelope protein
stranded DNA using pBR322-specific oligonucleotides
eliminates proteolytic cleavage and transport of gp160,
as primers. Sequence of part of BamHI fragment 3 com-
thus preventing env-mediated fusion (Li et al., 1993; Dash prising genes UL6 to UL12 of strain Kaplan has been
et al., 1994). In contrast, other proteins which normally reported previously (Dijkstra et al., 1997a; GenEMBL Ac-
contain N-linked oligosaccharides may not or only mar- cession No. X97257).
ginally be affected. In bovine herpesvirus 1 (BHV-1) gD
absence of one or both N-glycans affects conformation
In vitro transcription and translation
of the protein but does not prevent processing and trans-
port to the cell surface (Tikoo et al., 1993). In HSV-1 Coupled in vitro transcription/translation (TNT, Pro-
all consensus N-glycan addition sequences in gD were mega, Mannheim, Germany) was done as described
mutated which influenced protein structure but had only (Dijkstra et al., 1996). For in vitro processing, microsomal
very little effect on gD function in virus infection in cell membranes were included in the reaction.
culture (Sodora et al., 1991a; 1991b). Plaques developed
more slowly and were only half the size of wild-type Construction of PrV mutants PrV-DgMß, PrV-DgMßR,
plaques, but kinetics of virus production, rate of virus and PrV-dgM
entry, and turnover rate of gD were not altered (Sodora
For construction of a gM deletion mutant, plasmidet al., 1991b).
TN47-913DSal was linearized with KpnI, and BamHI link-In this study, we analyzed glycosylation of PrV gM and
ers were added after blunt-ending with T4 polymerase.describe a natural PrV mutant expressing a nonglycosyl-
The resulting plasmid was cleaved with SalI and BamHI,ated gM.
thus deleting 688 bp of UL10 coding region, and a 3.5-
kb SalI/BamHI gG-lacZ expression cassette (Mettenleiter
and Rauh, 1990) was inserted in parallel transcriptionalMATERIAL AND METHODS
orientation giving rise to plasmid DUL10ß. This plasmid
was cotransfected with wild-type PrV DNA into Vero cellsCells and viruses
and virus progeny was screened under an agarose over-
Wild-type PrV strains Kaplan (PrV-Ka; Kaplan and Vat- lay containing 300 mg/ml of BluoGal (Gibco BRL, Eg-
ter, 1959), NIA-3 (Baskerville et al., 1973), and Becker genstein, Germany) for blue staining plaques. Plaque pu-
(Robbins et al., 1984), as well as vaccine strain Bartha rification was repeated until all plaques stained blue.
(PrV-Ba; Bartha, 1961), were grown on African green One randomly selected plaque isolate, PrV-DgMß (Fig.
monkey (Vero), bovine (MDBK), or porcine kidney cells 1), was further characterized.
(PSEK). Cells were cultured in Eagles´ minimum essential For isolation of a rescuant virus, DNA of PrV-DgMß
medium containing 5% fetal calf serum. Cotransfections was cotransfected with a BstEII/SphI fragment containing
were performed by the calcium phosphate coprecipita- genes UL10, UL11, and UL12 (Fig.1). Progeny virus was
tion technique (Graham and van der Eb, 1973) on Vero again assayed under BluoGal agarose and white plaques
were purified. One plaque isolate, PrV-DgMßR, in whichcells.
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FIG. 1. Construction of PrV gM mutants. In (a) a schematic diagram of the PrV genome, consisting of a unique long (UL) and a unique short
region (US) which is bracketed by inverted repeats (TR, terminal repeat; IR, inverted repeat), is shown. In (b) a BamHI restriction map is given with
an enlargement of the region of BamHI fragment 3 encoding genes UL13 to UL9. Location and orientation of the identified open reading frames is
presented as are relevant restriction sites used for cloning (K, KpnI; B, BamHI; S, SalI; Sp, SphI; Bs, BstEII). The shaded box shows the SalI fragment
deleted in plasmid TN47-913DSal. Numbers correspond to GENEMBL Accession No. X97257. (d) Insertion of the gG-lacZ expression cassette in PrV-
DgMß. (e) The fragment used for rescue of the gM mutation resulting in PrV-DgMßR. (f) The DNA fragment of PrV strain Bartha used to produce
PrV-dgM.
gM expression had been restored, was selected for fur- cell lysate) were heated in 1% SDS for 3 min at 957 and
subsequently incubated with 4 mU endo-ß-N-acetylglu-ther studies. Mutant PrV-dgM, which carries the UL10
gene of PrV-Ba instead of the PrV-Ka homolog, was iso- cosaminidase H (EndoH; Boehringer-Mannheim, Ger-
many) in 50 mM sodium citrate, pH 5.0, for 16 hr. Forlated after cotransfection of PrV-DgMß DNA with plasmid
pUCBarthaSphIDSal. After BluoGal agarose overlay a complete removal of all N-linked carbohydrates, proteins
were incubated for 3 min at 957 in 1% SDS and digestedcolorless plaque was purified to homogeneity and further
characterized. Correct insertion and deletion of the re- for 16 hr in 50 mM potassium phosphate buffer (pH 7.4) –
0.6% 3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-pro-spective fragments was verified by restriction enzyme
digests and Southern blot analysis using standard proce- panesulfonate (CHAPS)–0.1% SDS–25 mM EDTA with
0.4 U of PNGaseF (Boehringer, Mannheim, Germany)dures (Sambrook et al., 1989).
prior to gel electrophoresis and Western blotting.
Western blots of infected cell lysates or purified
virions
One-step growth, penetration kinetics, and
Virus purification and preparation of infected cell ly- determination of plaque size
sates was performed as described (Klupp et al., 1992).
For analysis of growth behavior MDBK and Vero cellsProteins were separated under reducing conditions in
were infected with a m.o.i. of 5 with wild-type PrV-Ka,sodium dodecyl sulfate (SDS)–10% or 12% polyacryl-
PrV-DgMß, PrV-DgMßR, or PrV-dgM. After 1 hr of adsorp-amide gels (Laemmli, 1970). Samples were not heated
tion on ice, the inoculum was substituted by fresh pre-prior to loading onto the gel, since PrV gM tends to aggre-
warmed medium to start penetration which was allowedgate during incubation at 957 (Dijkstra et al., 1996). After
for 2 hr at 377. Then remaining extracellular virus wastransfer to nitrocellulose (Towbin et al., 1979), filters were
inactivated by low pH treatment. Immediately thereafterincubated with rabbit anti-peptide serum specific for gM
and after 4, 8, 12, 24, and 36 hr, supernatant and infected(Dijkstra et al., 1996). Bound antibody was visualized after
cells were harvested separately and titrated. Since noincubation with a secondary peroxidase-conjugated anti-
difference in the ratio of intra- and extracellular virusrabbit antibody by enhanced chemiluminescence (Amer-
was observed between the different viruses, titers weresham, Braunschweig, Germany).
added and plotted into a single curve.
Glycosidase digestions To monitor kinetics of penetration, MDBK and Vero
cells were infected with approximately 500 PFU per wellTo remove high-mannose forms of N-linked carbohy-
drates, proteins (6 mg of purified virus or 12 mg of infected of a 6-well culture dish. Virus was allowed to adsorb
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molecular mass of 2–3 kDa onto both forms. After diges-
tion of in vitro translation products with EndoH before
electrophoresis and Western blotting, proteins of 33 and
30 kDa were again observed (Fig.2, lane 3), indicating
that both proteins were indeed modified by addition of
N-glycans.
To further investigate processing of PrV gM, Western
blots on PrV-infected cell lysates and purified virions
were performed. As described recently (Dijkstra et al.,
1996), the anti-gM serum reacted with 45- and 90-kDaFIG. 2. In vitro translation and processing of the UL10 protein. Protein
proteins in purified virion preparations (Fig.3, lane 1). Inproducts generated by coupled in vitro transcription/translation reac-
infected cell lysates 35- and 70-kDa proteins were de-tion in the absence (lane 1) or presence of canine microsomal mem-
branes (lanes 2 and 3) were separated in a SDS–12% polyacrylamide tected in addition to the 45-kDa polypeptide (Fig.3, lane
gel under reducing conditions. In lane 3, translation products were 7). After PNGaseF treatment the 45-kDa protein in puri-
treated with EndoH before gel electrophoresis. Shown is a fluorograph fied virions (Fig.3, lane 4) as well as the 45- and 35-kDaof [35S]methionine-labeled total reaction products. Molecular mass is
forms in infected cell lysates were no longer detectable.indicated on the left. The arrow indicates the shift in electrophoretic
Instead, a 33-kDa protein appeared which was specifi-mobility of the 35- and 33-kDa proteins after EndoH digest.
cally detected by the anti-gM serum (Fig.3, lanes 4 and
10). The electrophoretic mobility of the higher molecular
during a 1-hr incubation period on ice. Thereafter, the weight form found in purified virion preparations as well
inoculum was removed and cells were overlaid with fresh as in infected cell lysates was also increased. Since the
prewarmed medium. Immediately after the temperature 33-kDa protein is of the same size as the in vitro transla-
shift and at different times thereafter, medium was re- tion product (Fig.2, lane 1), we hypothesize that it repre-
moved and the monolayer was overlaid with 40 mM citric sents the nonglycosylated UL10 precursor protein. The
acid–10 mM KCl–135 mM NaCl (pH 3.0) for 2 min. Cells 35-kDa form is sensitive to EndoH digestion after in vitro
were then washed twice with PBS and incubated under processing (Fig.2, lane 3) as well as in infected cells
methylcellulose medium at 377 until plaques were visible. (Fig.3, lane 12), indicating that it is modified by addition
Cells were fixed with 5% formaldehyde and stained with of a high-mannose glycan. Although the 35-kDa protein
crystal violet. Plaques were counted and values were was not completely converted to the 33-kDa form by
calculated with reference to control plates which had EndoH treatment under these conditions, by using less
been incubated with PBS only. Results are given as per- protein complete conversion of the 35-kDa form to the
centage of PFU surviving low pH treatment. 33-kDa protein was achieved (data not shown). The pre-
Plaque size was measured after titration of PrV-Ka and sumed dimeric 70-kDa form in infected cells was re-
the different mutants on MDBK and Vero cells. After 3 duced to 65 kDa by EndoH treatment, indicating that
days incubation at 377 under a methylcellulose overlay, the 70-kDa protein represents a gM dimer with high-
cells were fixed with 5% formaldehyde and stained with
crystal violet. Fifty plaques were measured microscopi-
cally for each virus, and average plaque size was deter-
mined. Values were calculated in comparison to PrV-Ka
taken as 100%. Average percentages as well as standard
deviation were determined from six independent experi-
ments.
RESULTS
Processing of PrV gM in vitro and in cell culture
In vitro translation of in vitro-transcribed UL10 mRNA
resulted in products of 33 and 30 kDa (Fig.2, lane 1),
FIG. 3. Immunoblot analysis of purified virions and infected cell ly-
which are both recognized by the anti-gM sera (Dijkstra sates. 6 mg protein of purified PrV-Ka (lanes 1, 3–6) or PrV-DgMß
et al., 1996). The smaller protein most likely results from virions (lane 2), or 12 mg protein of PrV-Ka (lanes 7, 9–12) or PrV-
DgMß-infected cell lysate (lane 8) were separated directly (lanes 1, 2,internal translation initation at a second methionine co-
7, and 8), after overnight incubation with PNGaseF (lanes 4 and 10),don located 40 amino acids downstream of the first ATG.
or after EndoH digestion (lanes 6 and 12) in a reducing SDS–10%In the presence of canine microsomal membranes prod-
polyacrylamide gel. After transfer to nitrocellulose filters were incu-
ucts of 33 and 35 kDa were observed (Fig.2, lane 2). This bated with the anti-gM peptide serum. Molecular masses of the identi-
difference in electrophoretic mobility is consistent with fied proteins are given on the right. Lanes 3, 5, 9, and 11 are control
incubations in the respective buffer without enzyme.addition of one high-mannose glycan with a calculated
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60 of the UL10 open reading frame (Fig.5b; Dijkstra et al.,
1996). Threonine at position 59 is part of the consensus
sequence for addition of N-glycans, NDT (Kornfeld and
Kornfeld, 1985). Its alteration to alanine thus resulted in
elimination of the N-glycosylation signal. This shows that
the Bartha UL10 gene product is not N-glycosylated be-
cause the consensus sequence for N-glycan addition
was modified.
Isolation of PrV-Ka mutant expressing
nonglycosylated UL10 protein
We recently described construction of a mutant in
FIG. 4. Immunoblot analysis of purified virions. Purified virion prepa-
which approximately 60% of UL10 coding sequencesrations of PrV-Ka (lane 1), PrV-Ba (lane 2), PrV-DgMß (lane 3), PrV-dgM
were deleted and substituted by the gB gene of BHV-1(lane 4), as well as PrV-Ka-infected cell lysate (lane 5) were electropho-
retically separated in a SDS–12% polyacrylamide gel. After transfer to (Dijkstra et al., 1996). This mutant PrV-DgMgB was im-
nitrocellulose, filters were incubated with the anti-gM serum. Proteins paired in penetration and replicated to 10- to 50-fold
were visualized by enhanced chemiluminescence after incubation with reduced titers. To facilitate further manipulation of the
a peroxidase-conjugated anti-rabbit antibody. Molecular masses of the
UL10 gene, we isolated a lacZ insertion mutant of PrV-proteins are given on the left.
Ka. To this end, a gG-lacZ expression cassette (Metten-
leiter and Rauh, 1990) was inserted into the partially de-
leted UL10 gene in parallel transcriptional orientationmannose N-glycans. The 45-kDa mature gM is EndoH
(Fig.1). The resulting mutant virus, PrV-DgMß, also repli-resistant as is the 90-kDa protein (Fig.3, lanes 6 and 12).
cated to reduced titers (Fig.6) and showed a delay inTreatment with neuraminidase and O-glycosidase
penetration (Fig.7) compared to PrV-Ka, which parallelsdid not increase electrophoretic mobility of the gM pro-
the results for PrV-DgMgB (Dijkstra et al., 1996). No gM-teins, indicating that PrV gM does not contain appre-
specific proteins were detectable either in Western blotciable amounts of O-linked glycans (data not shown).
analysis (Fig.3, lanes 2 and 8; Fig.4, lane 3) or indirectSince the deglycosylated form of gM still migrates as
immunofluorescence assays (data not shown).a relatively broad band, other modifications may, how-
To analyze whether the nonglycosylated UL10 pro-ever, be present.
tein is functionally competent, the mutated Bartha
UL10 protein of PrV-Ba is not N-glycosylated UL10 gene was used to replace wild-type UL10 in PrV-
Ka. To this end, cotransfections were performed with
To investigate whether processing of gM is identical
DNA of PrV-DgMß, and plasmid pUCBarthaSphIDSal
in different PrV strains, Western blot analysis on puri-
encompassing the UL10, UL11, UL12, and part of UL13
fied virions of PrV strains NIA-3, Becker, and PrV-Ba
genes of PrV strain Bartha. Under BluoGal overlay a
were performed. While in strains NIA-3 and Becker the
colorless plaque was picked and purified to homoge-
same pattern of gM-specific proteins appeared as in
neity. This mutant was designated as PrV-dgM. West-
strain Kaplan (Fig.4, lane 1 and data not shown), in
ern blot analyses of purified virions showed that PrV-
PrV-Ba proteins of 65, 33, and 29 kDa were observed
dgM expressed nonglycosylated forms of gM similar
(Fig.4, lane 2). None of these proteins exhibited an
to PrV strain Bartha (Fig.4, lane 4). A corresponding
increased mobility after PNGase F digestion, indicat-
rescuant with wild-type UL10 was isolated by the same
ing that they were not N-glycosylated (data not shown).
approach and designated PrV-DgMßR. Southern blot
For comparison, analysis of PrV-Ka-infected cell lysate
and Western blot analyses were performed to verify
is shown in Fig.4, lane 5. The 65- and 33-kDa polypep-
restoration of UL10 (data not shown).
tides match in size to respective products obtained
after enzymatic deglycosylation of PrV-Ka gM proteins Growth characteristics of PrV-DgMß, PrV-DgMßR,
(see Fig. 3). Origin of the 29-kDa polypeptide is unclear and PrV-dgM
at present.
To look for the reason for this surprising finding, the To investigate whether the N-glycosylation site is im-
portant for gM function in virus replication in cell culture,UL10 gene of PrV strain Bartha was cloned and se-
quenced. Compared to PrV strain Kaplan only two nucle- growth characteristics of PrV-Ka and mutants PrV-DgMß,
PrV-DgMßR, and PrV-dgM were compared in one-stepotide exchanges were detected. Nucleotide A at position
176 of the UL10 open reading frame was changed to G, growth kinetics, penetration assays, and plaque size de-
terminations.and T at position 179 was modified to C (Fig.5a). Both
mutations resulted in amino acid changes, threonine to To assess the rate and amount of virus production,
one-step growth kinetics were established on MDBK (Fig.alanine at position 59, and serine to proline at position
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FIG. 5. Nucleotide and deduced amino acid sequence of UL10 of PrV-Ka and PrV-Ba. Sequence of a region comprising PrV-Ka (Kaplan) genes
UL6 to UL12 was reported previously (Dijkstra et al., 1997a). The PrV-Ba (Bartha) UL10 gene was sequenced in this study. Nucleotide sequence
comparison revealed two differences at positions 175 (A r G) and 178 (T r C; indicated by arrows). Correspondingly, the amino acid at position
59 was altered from threonine (T), which is part of the N-glycosylation consensus sequence (depicted in bold letters) to alanine (A), and serine (S),
at position 60, was changed to proline (P). No other difference between the two UL10 sequences could be identified.
6A) and Vero cells (Fig. 6B). Results were essentially delayed entry in both cell types with 50% of PFU protected
from inactivation at 18 and 30 min after temperature shift,the same on both cell lines. As previously described for
mutant PrV-DgMgB (Dijkstra et al., 1996), PrV-DgMß (j) respectively (Fig.7, j). PrV-dgM (Fig.7, l) efficiently pen-
etrated into MDBK cells with a 50% value of 5 min. Thus,showed a delay in onset of production of infectious virus,
and final titers were reduced ca. 20-fold compared to absence of N-glycans on gM does not alter the ability of
the virus to penetrate into MDBK cells. In contrast, PrV-PrV-Ka (x). This growth defect could be compensated by
rescue with wild-type UL10 (PrV-DgMßR; l). Interest- dgM exhibited a delay in entry into Vero cells with 50%
PFU protected at 18 min after temperature shift.ingly, rescue with Bartha UL10 encoding the nonglycosyl-
ated form of gM (PrV-dgM; l) also resulted in wild-type- To investigate the effect of N-glycosylation of PrV gM
on plaque size, PrV-Ka, PrV-DgMß, PrV-DgMßR, and PrV-like one-step growth; i.e., early onset of virus production
and higher final titers. Since no difference was observed dgM were plated onto MDBK and Vero cells under
plaque assay conditions. Three days after infection thein the ratio between intracellular and extracellular virus
in any of the mutants tested, values were combined and sizes of 50 plaques for each virus were measured micro-
scopically. The value for PrV-Ka was set as 100% andplotted into a single curve. These results indicate that
N-glycosylation is not required for gM function as as- plaque size of the mutants was calculated accordingly
(Fig.8). Plaque sizes of PrV-Ka and PrV-DgMßR weresessed by one-step growth kinetics.
Since mutant PrV-DgMgB was shown to exhibit a delay comparable, whereas those of PrV-DgMß and PrV-dgM
were 29 and 28% smaller on Vero cells, and 31 and 20%in penetration (Dijkstra et al., 1996), penetration kinetics
into MDBK and Vero cells were analyzed (Fig.7). PrV-Ka smaller on MDBK cells, respectively. This indicates that
absence of gM slightly impairs direct cell-to-cell-spread,(Fig. 7, x) and rescuant PrV-DgMßR (Fig. 7, l) penetrated
with equal efficiency with 50% values on MDBK of ca. 4 a defect which is not compensated for by the nonglyco-
sylated form of gM.min, and on Vero of ca. 8 min. PrV-DgMß exhibited a
FIG. 6. One-step growth kinetics. MDBK (A) and Vero cells (B) were infected with PrV-Ka (-x-), PrV-DgMß (-j-), PrV-DgMßR (-l-), or PrV-dgM
(-l-) with an m.o.i. of 5. Supernatants and infected cells were harvested at the times indicated, and progeny virus titers were determined on Vero
cells. Data from a representative experiment are shown. Values were calculated by addition of extracellular and intracellular virus titers.
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FIG. 7. Penetration kinetics of virus mutants. Entry kinetics into MDBK (A) and Vero cells (B) of PrV-Ka (-x-), PrV-DgMß (-j-), PrV-DgMßR (-l-),
and PrV-dgM (-l-) were determined after low-pH inactivation. The number of plaque forming units resistant to the low-pH treatment is given as
percentage of the number of plaques on control plates. Data represent averages from three independent experiments. Vertical lines indicate
standard deviation.
DISCUSSION (Dijkstra et al., 1996), which are reduced by PNGaseF
digestion to 65- and 33-kDa proteins. The 65-kDa form
Glycoprotein M is the only nonessential glycoprotein
presumably constitutes a nonglycosylated dimer. We
described so far, which is conserved throughout the her-
hypothesize that PrV UL10 is translated into a 33-kDa
pesvirus family (Baines and Roizman, 1993; MacLean et
precursor protein which is modified by addition of oneal., 1993; Dijkstra et al., 1996; Osterrieder et al., 1996).
high-mannose N-glycan to a 35-kDa product. This En-Other conserved glycoproteins are the essential gB, gH,
doH-sensitive form is processed into the mature, EndoH-and gL, which are required for virus entry and direct
resistant 45-kDa gM, which is incorporated into the vi-cell-to-cell spread (reviewed in Spear, 1993; Mettenleiter,
rion. Whereas the high-mannose form of gM was never1994b). Although the gene coding for another nonessen-
detected in purified virion preparations, the 33-kDa non-tial glycoprotein of PrV, gN (Jo¨ns et al., 1996), is also
glycosylated precursor was sometimes observed in lowconserved within the Herpesviridae, its gene product is
amounts (Dijkstra et al., 1996). Origin of a 29-kDa proteinapparently not glycosylated in HSV-1 (Barnett et al., 1992;
also detected in infected cell lysates is unclear. ThisAdams et al., 1996) and BHV-1 (Liang et al., 1996). A gN-
protein might represent a break-down product or corre-PrV mutant was found to be slightly impaired in penetra-
spond to a 30-kDa protein detected after in vitro tran-tion and in cell-to-cell spread (A. Jo¨ns, unpublished re-
scription/translation which is attributed to internal initia-sults). However, no prominent functional role could so
tion of translation at a second downstream in-frame me-far be assigned to gN to explain the high conservation.
thionine (Dijkstra et al., 1996). Thus, the processingSimilarly, analyses of gM0mutants of HSV-1 or EHV-1
pattern of PrV gM resembles that recently proposed fordid not reveal a particularly striking phenotype in either
gM of EHV-1 (Osterrieder et al., 1997).cell culture or model host (Baines and Roizman, 1993;
N-glycosylation generally occurs at the sequence NXT/MacLean et al., 1993; Osterrieder et al., 1996). This con-
S, in which X can be any amino acid except prolinetrasts the high conservation of several structural features
(Kornfeld and Kornfeld, 1985). Core glycosylation haswithin the gM homologs, which, among others, includes
been shown to be inefficient if the central amino acida N-glycosylation motif between the first and second hy-
constitutes W (Trp), D (Glu), K (Lys), or L (Leu) (Shakin-drophobic domain. Recently, we described the identifica-
Eshleman et al., 1996). In PrV UL10, the only N-glycosyla-tion of PrV gM as a component of purified virions (Dijkstra
tion sequence present is NDT, which has a predictedet al., 1996). Because of its apparent abundance and its
efficiency of only 20% (Shakin-Eshleman et al., 1996).conservation, we focused on analyzing gM processing
However, our studies show efficient use of this N-glyco-and function in more detail. We show here that PrV gM
sylation site both in vitro and in infected cells.is modified by addition of an N-glycan in vitro and in
Surprisingly, despite the obvious conservation of theinfected cells. After in vitro translation a prominent prod-
N-glycosylation site between the first and second hy-uct of 33 kDa appeared which was processed in the
drophobic domain, in purified virion preparations of PrV-presence of microsomal membranes into a 35-kDa form.
Ba gM forms with sizes corresponding to the nonglyco-A protein of similar size was also present in infected cell
sylated proteins, i.e., major 65- and 33-kDa proteins werelysates and has been found to be sensitive to Endo H
digestion. Purified virions contain 45- and 90-kDa forms observed. Sequence analysis confirmed that the UL10
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FIG. 8. Plaque sizes of mutant viruses. Vero (white bars) and MDBK cells (dotted bars) were infected with PrV-Ka, PrV-DgMß, PrV-DgMßR, and
PrV-dgM under plaque assay conditions. After 3 days of incubation under methylcellulose medium, cells were fixed and plaques were microscopically
measured. Relative diameters compared to the size of plaques produced by PrV-Ka were calculated. Mean values and standard deviation of six
independent experiments are shown.
gene of strain Bartha as compared to PrV-Ka contained tribute the slight phenotypic alterations to the lack of
N-glycosylation, the serine to proline mutation, or both.two mutations in close proximity which both lead to
amino acid exchanges. One of them results in an amino Nevertheless, it is clear from our results that neither one
had a striking effect on gM function. Replacement of theacid exchange from serine to proline which may influ-
ence secondary structure of the protein. The other muta- mutated UL10 gene in strain Bartha by the wild-type
strain Ka allele did not alter one-step growth kinetics,tion altered the N-glycosylation signal NDT to NDA.
Therefore, PrV-Ba is unable to express a glycosylated penetration kinetics, or plaque size phenotype of Bartha
(data not shown).form of the UL10 gene product. Nevertheless, the nongly-
cosylated form appeared to dimerize, as deduced from PrV strain Bartha has been isolated after intensive pas-
saging on chicken-derived cells (Bartha, 1961). Attenua-the presence of a 65-kDa protein, and it is incorporated
into virions. Thus, N-glycosylation is not required for vi- tion during passaging resulted in its use as a successful
live vaccine against Aujeszky’s disease in pigs. We re-rion localization of the UL10 protein.
Based on the availability of a natural UL10 glycosyla- cently showed that deletion of gM led to a marked attenu-
ation of PrV for pigs (Dijkstra et al., 1997b). Therefore, ittion mutant, importance of N-glycosylation of the UL10
protein for function in a wild-type background was ana- is tempting to speculate that the gM mutation in strain
Bartha might contribute to its attenuated character. How-lyzed by substituting the PrV-Ka UL10 gene with PrV-Ba
UL10 and comparing replication to a gM0deletion mu- ever, none of the mutations which have been found by
marker rescue to be associated with avirulence of straintant. In one-step growth, the nonglycosylated UL10 pro-
tein fully complemented absence of wild-type gM, indi- Bartha maps to the region encoding gM. They include a
deletion of gE/gI (Mettenleiter et al., 1985; Petrovskis etcating that N-glycosylation of the UL10 protein is not
required for efficient virus replication. Only slight pheno- al., 1986), a signal sequence mutation in gC (Robbins et
al., 1984), and mutations within the UL21 gene (Klupp ettypic alterations such as delayed entry kinetics or reduc-
tion in plaque size were observed when mutant PrV-dgM al., 1995). Repair of these defects fully restored virulence,
which indicates that the gM mutation does not signifi-was compared to PrV-Ka or wild-type UL10 rescuant PrV-
DgMßR. In summary, the phenotypes associated with cantly contribute to attenuation of PrV strain Bartha.
Thus, a possible functional role for glycosylation of gMlack of glycosylation of the UL10 protein were subtle. A
similar finding has recently been reported by Galdiero remains elusive. N-glycans have been shown to be able
to mask antigenic epitopes, thereby probably providinget al., who analyzed the importance of a conserved N-
glycosylation site in the essential glycoprotein H. These the virus with an advantage in combat with the host’s
immune system (Olden et al., 1985; Sodora et al., 1989;authors demonstrated that site-directed mutagenesis of
the N-glycosylation motif did not result in an appreciable Qiu et al., 1992b). PrV-infected pigs mount an antibody
response to gM, but gM does not appear to be prominentalteration of protein structure or function (Galdiero et
al., 1996). Since UL10 of PrV-Ba contains an additional among the PrV glycoproteins in induction of an antibody
response, nor has it been shown to represent an im-mutation in close proximity, we cannot unequivocally at-
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function of the hemagglutinin of influenza virus. J. Virol. 66, 7136–portant protective immunogen (Dijkstra et al., 1997b). Pre-
7145.dicted antigenic sites within gM are located around the
Graham, F. L., and van der Eb, A. J. (1973). A new technique for the
conserved glycosylation site and at the carboxyterminus assay of infectivity of human adenovirus. Virology 52, 456–467.
of the protein (Dijkstra et al., 1996). Although it is dis- Henikoff, G. (1993). Undirectional digestion with exonuclease III creates
targeted breakpoints for DNA sequencing. Gene 28, 351–359.cussed that the carboxyterminal part of gM might not be
Jo¨ns, A., Granzow, H., Kuchling, R., and Mettenleiter, T. C. (1996). Theexposed on the surface of virion or infected cell (Baines
UL49.5 gene of pseudorabies virus codes for an O-glycosylated pro-and Roizman, 1993; Dijkstra et al., 1996, Osterrieder et
tein of the viral envelope. J. Virol. 70, 1237–1241.
al., 1996), at present we cannot exclude that glycosylation Johnson, D. C., and Spear, P. G. (1982). Monensin inhibits processing
of gM could serve to mask epitopes. of herpes simplex virus glycoproteins, their transport to the cell sur-
face, and the egress of virions from infected cells. J. Virol. 43, 1102–In summary, we show that gM of PrV-Ka is modified
1112.by addition of an N-linked glycan at a single conserved
Kaplan, A. S., and Vatter, A. E. (1959). A comparison of herpes simplexN-glycosylation site. Isolation of a natural PrV mutant
and pseudorabies viruses. Virology 7, 394–407.
with a mutation which led to inactivation of this site dem- Klupp, B. G., Visser, N., and Mettenleiter, T. C. (1992). Identification and
onstrates that glycosylation of gM does not appear to characterization of pseudorabies virus glycoprotein H. J. Virol. 66,
3048–3055.be of overt importance for its function. Therefore, the
Klupp, B. G., Lomniczi, B., Visser, N., Fuchs, W., and Mettenleiter, T. C.conservation of this glycosylation site within gM homo-
(1995). Mutations affecting the UL21 gene contribute to avirulencelogs of all three subfamilies of herpesviruses remains
of pseudorabies virus vaccine strain Bartha. Virology 212, 466–473.
puzzling. Kornfeld, R., and Kornfeld, S. (1985). Assembly of asparagine linked
oligosaccharides. Annu. Rev. Biochem. 54, 631–664.
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